Pimasertib hydrochloride/SAR-405838

盐酸派吗色替/SAR-405838

Report date: 2022/01/29 17:55:20

Base Information

Drug NamePimasertib hydrochloride/SAR-405838
Drug Alias Name盐酸派吗色替和SAR-405838Pimasertib hydrochloride+SAR-405838盐酸派吗色替SAR-405838 + pimasertib hydrochloride盐酸派吗色替-SAR-405838 +[15] 
ClassificationSmall molecules
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 1 inhibitorsp53-binding protein Mdm-2 inhibitorsDual specificity mitogen-activated protein kinase kinase 2 inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase 2p53-binding protein Mdm-2Dual specificity mitogen-activated protein kinase kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes SAR-405838Pimasertib hydrochloride
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofiMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofiMerck Serono
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A